Revolutionizing CAR T-Cell Therapy: Cellectis’ Groundbreaking Discovery Published in Nature Communications
New Biotechnology Company Making Waves in the Industry June 30, 2022 Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company June 30, 2022 – Cellectis is making headlines in the biotechnology industry with its innovative approaches to clinical-stage research. The company, known for its cutting-edge technology and groundbreaking discoveries, is creating…